Annual D&A
N/A
30 April 2024
Summary:
PharmaCyte Biotech annual depreciation & amortization is not available.PMCB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
N/A
31 July 2024
Summary:
PharmaCyte Biotech quarterly depreciation & amortization is not available.PMCB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
N/A
31 July 2024
Summary:
PharmaCyte Biotech TTM depreciation & amortization is not available.PMCB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
PMCB Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
PharmaCyte Biotech Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Apr 2012 | $24.70 K(-39.3%) | $800.00(-89.3%) | $24.70 K(-23.8%) |
Jan 2012 | - | $7500.00(-5.1%) | $32.40 K(-5.0%) |
Oct 2011 | - | $7900.00(-7.1%) | $34.10 K(-8.3%) |
July 2011 | - | $8500.00(0.0%) | $37.20 K(-8.6%) |
Apr 2011 | $40.70 K(-64.6%) | $8500.00(-7.6%) | $40.70 K(-25.7%) |
Jan 2011 | - | $9200.00(-16.4%) | $54.80 K(-24.7%) |
Oct 2010 | - | $11.00 K(-8.3%) | $72.80 K(-22.8%) |
July 2010 | - | $12.00 K(-46.9%) | $94.30 K(-18.0%) |
Apr 2010 | $114.90 K(+300.3%) | $22.60 K(-16.9%) | $115.00 K(+0.7%) |
Jan 2010 | - | $27.20 K(-16.3%) | $114.20 K(+27.9%) |
Oct 2009 | - | $32.50 K(-0.6%) | $89.30 K(+51.6%) |
July 2009 | - | $32.70 K(+50.0%) | $58.90 K(+105.2%) |
Apr 2009 | $28.70 K | $21.80 K(+847.8%) | $28.70 K(+215.4%) |
Jan 2009 | - | $2300.00(+9.5%) | $9100.00(+3.4%) |
Oct 2008 | - | $2100.00(-16.0%) | $8800.00(+12.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
July 2008 | - | $2500.00(+13.6%) | $7800.00(+23.8%) |
Apr 2008 | $6400.00(+357.1%) | $2200.00(+10.0%) | $6300.00(+43.2%) |
Jan 2008 | - | $2000.00(+81.8%) | $4400.00(+57.1%) |
Oct 2007 | - | $1100.00(+10.0%) | $2800.00(+40.0%) |
July 2007 | - | $1000.00(+233.3%) | $2000.00(+53.8%) |
Apr 2007 | $1400.00(+180.0%) | $300.00(-25.0%) | $1300.00(0.0%) |
Jan 2007 | - | $400.00(+33.3%) | $1300.00(+18.2%) |
Oct 2006 | - | $300.00(0.0%) | $1100.00(-116.4%) |
July 2006 | - | $300.00(0.0%) | -$6700.00(-1440.0%) |
Apr 2006 | $500.00 | $300.00(+50.0%) | $500.00(+150.0%) |
Jan 2006 | - | $200.00(-102.7%) | $200.00(>+9900.0%) |
Oct 2005 | - | -$7500.00(-200.0%) | $0.00(-100.0%) |
July 2005 | - | $7500.00(-568.8%) | $5900.00(>+9900.0%) |
Oct 2004 | - | -$1600.00(-200.0%) | $0.00(-100.0%) |
July 2004 | - | $1600.00 | $1600.00 |
FAQ
- What is the all time high annual D&A for PharmaCyte Biotech?
- What is the all time high quarterly D&A for PharmaCyte Biotech?
- What is the all time high TTM D&A for PharmaCyte Biotech?
What is the all time high annual D&A for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual depreciation & amortization is $114.90 K
What is the all time high quarterly D&A for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly depreciation & amortization is $32.70 K
What is the all time high TTM D&A for PharmaCyte Biotech?
PharmaCyte Biotech all-time high TTM depreciation & amortization is $115.00 K